Long‐acting relaxin for pulmonary hypertension: from systemic pharmacodynamics to disease‐site pharmacology
British Journal of Pharmacology · 07.07.2026
DOI: 10.1111/bph.70595 ↗Kurz gefasst
Leserbrief in der Zeitschrift British Journal of Pharmacology, online erschienen am 07.07.2026. Verfasst von Man Sun und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Second Hospital of Dalian Medical University, Dalian City, China. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Oncology, The Second Hospital of Dalian Medical University, Dalian City, China.
Zitieren
APA
Sun, M., Zang, D., & Chen, J. (2026). Long‐acting relaxin for pulmonary hypertension: from systemic pharmacodynamics to disease‐site pharmacology. British Journal of Pharmacology. https://doi.org/10.1111/bph.70595
Vancouver
Sun M, Zang D, Chen J. Long‐acting relaxin for pulmonary hypertension: from systemic pharmacodynamics to disease‐site pharmacology. British Journal of Pharmacology. 2026. doi:10.1111/bph.70595
BibTeX
@article{Sun2026,
author = {Sun, Man and Zang, Dan and Chen, Jun},
title = {Long‐acting relaxin for pulmonary hypertension: from systemic pharmacodynamics to disease‐site pharmacology},
journal = {British Journal of Pharmacology},
year = {2026},
doi = {10.1111/bph.70595}
}
EUVIMED